📰 Georgea Eldridge News
Georgea Eldridge News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Georgea Eldridge. Real-time updates on events, politics, business and more.
May 26, 2024
Wedbush reiterated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Wedbush currently has a $41.00 price target on the stock. Other analysts also recently issued reports about the stock. Jefferies Financial Group initiated coverage on shares of Aerovate Therapeutics in […]
May 26, 2024
Wedbush restated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report report published on Wednesday, Benzinga reports. The brokerage currently has a $41.00 price target on the stock. AVTE has been the subject of a number of other reports. Wells Fargo & Company reissued an overweight rating and […]
May 18, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares saw unusually-strong trading volume on Wednesday . Approximately 151,180 shares changed hands during trading, an increase of 15% from the previous session’s volume of 131,156 shares.The stock last traded at $20.38 and had previously closed at $19.28. Analysts Set New Price Targets Several research analysts have […]
April 24, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares saw strong trading volume on Wednesday . 197,194 shares traded hands during trading, an increase of 52% from the previous session’s volume of 129,738 shares.The stock last traded at $22.91 and had previously closed at $23.22. Wall Street Analysts Forecast Growth A number of research analysts […]
April 24, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares saw strong trading volume on Wednesday . 197,194 shares traded hands during trading, an increase of 52% from the previous session’s volume of 129,738 shares.The stock last traded at $22.91 and had previously closed at $23.22. Wall Street Analysts Forecast Growth A number of research analysts […]
April 5, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report)’s share price dropped 3.9% on Wednesday after an insider sold shares in the company. The company traded as low as $28.23 and last traded at $28.44. Approximately 5,463 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 121,717 shares. The […]
March 25, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) reached a new 52-week high on Monday . The company traded as high as $28.39 and last traded at $27.85, with a volume of 25873 shares trading hands. The stock had previously closed at $25.78. Analysts Set New Price Targets AVTE has been the subject of several […]
January 1, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,190,000 shares, an increase of 16.5% from the April 30th total of 1,880,000 shares. Based on an average daily trading volume, of 167,500 shares, the short-interest […]
March 1, 2023
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) was the target of a large decline in short interest during the month of February. As of February 15th, there was short interest totalling 960,000 shares, a decline of 53.2% from the January 31st total of 2,050,000 shares. Based on an average trading volume of 151,900 shares, the […]